Search the Newsreel

Nephros Inc (NEPH) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Nephros Inc (NEPH), detailing its current valuation score, P/E ratio, and market data. It highlights that the company's valuation score is 8.25, placing it 75th in its industry, and notes its P/E ratio of 46.43. The analysis …

Smith & Nephew Expands Wound Care Portfolio in $22B Market

Smith & Nephew (SNN) is expanding its wound care portfolio and addressing the chronic wound management market, which is projected to grow to over $30 billion by 2030. The company recently launched two new innovations, ALLEVYN COMPLETE CARE Foam Dressing and RENASYS EDGE Negative …

Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nephros Inc (NEPH), detailing its current price momentum score, identified support and resistance levels, and a summary of technical indicators and moving averages. According to the analysis, the stock is currently trading between $3.66 (resistance) and $3.01 …

Smith & Nephew PLC (SNN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Smith & Nephew PLC (SNN), highlighting its current valuation score and P/E ratio. The company's valuation score is 5.83, ranking it 190 out of 199 in the Healthcare Equipment & Supplies industry. While the P/E ratio is …

Neptune Insurance Holdings Inc. Just Beat Revenue Estimates By 6.5%

FTV VII., L.P. (NP) files to sell 1.87M Class A shares via Morgan Stanley

FTV VII., L.P. has filed to sell 1,867,840 Class A Common Stock shares of NP through Morgan Stanley & Co. LLC, with an aggregate market value of $62,049,644.80. These shares were converted from convertible preferred stock, originally acquired for cash in a private placement. …

BSIV Hold 101, LP (NYSE: NP) plans sale of 1.63M Class A shares

BSIV Hold 101, LP has filed to sell 1,632,160 Class A shares of NP (Neptune Insurance Holdings Inc.) through Morgan Stanley & Co. LLC, with an indicated market value of over $54 million. The sale is scheduled to begin on or after July 29, …

Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Smith+Nephew has received De Novo classification from the FDA for its TESSA Spatial Surgery System, marking a significant advancement in Sports Medicine. The system utilizes AI, augmented reality, and advanced imaging for personalized planning and real-time navigation during arthroscopic procedures, initially focusing on femoral …

Smith+Nephew's AI system overlays a 3D bone model in ACL surgery

Smith+Nephew has received FDA De Novo classification for its TESSA Spatial Surgery System, marking a new category for intra-articular orthopedic stereotaxic navigation instruments. The TESSA system uses AI and cloud-based deep learning algorithms to create patient-specific 3D anatomical models from pre-operative scans, which are …

Smith & Nephew agrees to settle ERISA class action with cash payments to plan participants

Smith & Nephew has agreed to a $350,000 settlement in an ERISA class action lawsuit, addressing allegations of excessive managed account service fees in its U.S. savings plan. Participants and beneficiaries from August 30, 2018, to May 13, 2026, are eligible for pro rata …

Smith & Nephew Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, Smith & Nephew plc has approximately 18,547 employees worldwide, marking a 1.3% decline since 2023 but a recovery from a low in 2025 Q1. The company is actively hiring with 1,218 active job postings in 2026, a 44.1% increase from …

NEPI Rockcastle N.V. Revenue Breakdown – JSE:NRP

Smith & Nephew PLC (SNN) Stock Up 4.6% but GF Value Says Overvalued -- GF Score: 84/100

Smith & Nephew PLC (SNN) saw its stock rise by 4.6% to $32.56, but GuruFocus's GF Value indicates it is 1.4% overvalued compared to its intrinsic value of $32.11. Despite this, SNN holds a strong GF Score of 84/100, driven by high profitability and …

Cevian Capital Lifts Smith & Nephew Stake Above 14% in Late-July Disclosure

Smith & Nephew SNATS (SNN) to Announce Quarterly Earnings on Tuesday

Neptune Insurance Holdings Ord Shs Class A Today's Market Trends | NP Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

This article provides a comprehensive overview of Neptune Insurance Holdings Ord Shs Class A (NP) stock, including real-time quotes, key financial figures, and market trends. It features analyst ratings, peer comparisons, technical indicators, and major shareholders. The stock currently has a "Buy" rating based …

Form 13D/A Smith & Nephew plc For: 27 July By Investing.com

This article announces the filing of Form 13D/A for Smith & Nephew plc on July 27th. Form 13D/A is an amendment to a Schedule 13D, which is filed with the SEC when a beneficial owner acquires more than 5% of a company's stock, indicating …

Cevian Capital reports 14.18% Smith & Nephew stake (NYSE: SNN)

Cevian Capital II GP Limited has reported a beneficial ownership of 119,179,419 ordinary shares in Smith & Nephew plc, representing 14.18% of the company's outstanding shares. The investment, totaling approximately $1.67 billion, was funded from Cevian Funds' general working capital, with sole voting and …

Nephros Inc (NEPH) Institutional Confidence

Nephros Inc (NEPH) has an institutional shareholding score of 5.00, placing it 96th out of 160 in its industry. The institutional shareholding proportion has increased by 6.10% quarter-over-quarter to 50.96%. James Simons is the largest institutional shareholder, holding 0.92% of outstanding shares.

Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey addresses the revenue breakdown for Nephros Inc (NEPH), detailing business segments, regional revenue, and profit contribution. It states that the relevant financial data for these categories have not yet been disclosed by the company. The page provides a general overview …

Are Smith & Nephew (LSE:SN) And Hikma Pharmaceuticals (LSE:HIK) Shaping Today's Healthcare Stocks Debate?

Smith & Nephew (NYSE: SNN) shows Cevian at 14.010786% voting stake

Smith & Nephew (NYSE: SNN) reported a significant change in major shareholding, with Cevian Capital II G.P. Limited now holding 14.010786% of voting rights, up from 13.206621%. This holding, totaling 117,912,733 voting rights, is primarily through Cevian Capital II Master Fund L.P. and Cevian …

Smith & Nephew stock holds steady on 2025 revenue and margin gains

Smith & Nephew's stock is supported by strong 2025 financial results, with revenue reaching $5.81 billion and an adjusted operating profit margin of 17.3%. The company demonstrated robust underlying revenue growth and significant margin improvement, indicating its ability to absorb pricing pressures and product-mix …

Neptune Insurance Holdings Ord Shs Class A (NP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Neptune Insurance Holdings Ord Shs Class A (NP) focusing on its dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years. The page also displays current stock information …

Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Nephros Inc (NEPH) dividends and stock splits. It states that no dividends have been distributed over the past five years. Key financial data like market cap and P/E ratio are also presented.

Nephros Inc. (NEPH) Retreats 3.45% as Stock Tests Key Support Zone - ATR Trailing Stop

Smith & Nephew plc Revenue Breakdown – LSE:SN.

Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Nephros Inc (NEPH), listing major individual and institutional holders and their respective proportions. It also provides a breakdown of shareholder types, including hedge funds and individual investors, and tracks institutional shareholding changes over several quarters. Key shareholders …

Smith & Nephew plc (SNN) latest stock news and headlines

This article provides a compilation of recent news and headlines regarding Smith & Nephew plc (SNN), a medical technology company. It highlights product launches, strategic expansions, expert consensus, and analyst and activist investor opinions affecting the stock's performance. The company's stock performance relative to …

NP|Neptune Insurance Holdings Ord Shs Class A|Price:30.240|Chg%:+0.390

This article provides detailed company information for Neptune Insurance Holdings Ord Shs Class A (NP), including its current stock price of $30.240, a daily change of +0.390 (+1.31%), and market capitalization of $4.15 billion. It lists key company executives and their shareholdings, as well …

NEPH|Nephros Inc|Price:3.450|Chg%:-0.190

This article provides a comprehensive stock analysis of Nephros Inc (NEPH) based on TradingKey's stock score system. It highlights the company's healthy fundamentals, high growth potential with steady revenue growth, and relatively fair valuation. The analysis also covers institutional ownership, analyst ratings, and a …

Smith+Nephew Expands ASC Platform to Support Value-Based Care

Smith+Nephew SNN recently unveiled an expanded ASC Solutions strategy aimed at helping ambulatory surgery centers ("ASCs") improve operational efficiency, accelerate growth and deliver better patient outcomes. The enhanced enterprise approach combines the company's procedural technologies, data-driven insights and strategic partner network to support ASC …

Smith & Nephew Advances $250 Million Share Buyback, Repurchasing Over 1 Million Shares in Latest Week

Smith & Nephew has announced the repurchase of 1,069,609 ordinary shares between July 17 and 23, 2026, as part of its $250 million share buyback program. The shares were acquired at an average price of 1,127.68 pence per share. Since the program began on …

Smith & Nephew stock trades steady as surgical portfolio supports earnings

Smith & Nephew's stock remains stable due to strong performance in its orthopedics and sports medicine franchises. The company reported increased revenue of $5.5 billion in fiscal 2024, up from $5.2 billion in 2023, and maintained a mid-teens trading margin despite investments in innovation …

What Smith & Nephew (LSE:SN) Says About The Current Blue-Chip Stocks Story

Nephrocare Health Services hosts Q1FY27 earnings call on Aug 12